Award-winning journalist Daniel Levine and bit.bio CEO Mark Kotter discuss industrialised cell programming and its use in research and cell therapy.
Award-winning journalist Daniel Levine and bit.bio CEO Mark Kotter discuss industrialised cell programming and its use in research and cell therapy.